Weight-loss drug boom reaches clothing store rack as America resizes

Jennifer Johnson, the founder of Florida’s largest clothing dealer True Fashionistas, began to notice anything unusual about a year ago. Suddenly, once again difficult to find, the larger dimensions became more common in clothing groups that came for re -sale. Since then, drip has become a torrent.

Johnson said historically loaded with extra small and small.

“We always wanted larger dimensions because they were popular – they would sell them immediately as soon as you bought them.” He said. “Now it is completely flip-floped. Now our extra small area is smaller than us.”

Johnson says that he closely monitors sales numbers and that the store in Florida is reset according to the inventory. The store had to be reset several times with more and more people abandoning larger dimensions.

Johnson says that the entrepreneurs at the country, re -sales, see this, and “Ozempic Effect”.

In Kansas City, Do Good Co. Janet Curran, who has a store named, said that the sales business exploded due to the Özempic effect. “We have seen a real change in our donation patterns and customer needs since more people started to use weight loss medications. Customers had demand for smaller dimensions and more frequent turnover as they went through different stages.” He said.

A RAND SURVEY Earlier this year, 11.8% of the US adults released were using GLP-1 drugs and 14% expressed their interest in using them. But so far, it is difficult to obtain evidence that retailers or clothing manufacturers have scaled larger production. In the meantime, clothing manufacturers and sellers do not say anything. Walmart and Levi Strauss refrained from commenting.

GLP-1 drugs change the larger size range in retail sales

Avneet Singh, the founder of Regent Row, the founder of the men’s clothing line, which appeals to big and long men and sold online to retailers such as Nordstrom and Macy’s, says changes.

According to Singh, “Retailers put a less expanded size on the shelf. After hitting 2xl and above, you will see more strict sizes and more ‘online’ label in the store.”

However, while the GLP-1 popularity causes a size shift, most of the shift is still in a larger size range-at least so far. Regent Row makes only XL and larger dimensions.

Singh, “GLP-1s, the size curve is moving to the left-5-6xl 3-4xl’ye changing men,” Singh said, this does not delete the inclusive sizing request, he added. “It’s just changing where the demand is sitting,” he added.

In addition, GLP-1s reduce the weight, while noting that it does not reduce the height. “Even if the waists fall, it will remain tall. If you ignore tall, you said that they thought most of the customers later.”

Before setting up the clothing brand, Singh worked as a buyer for Walmart and Zappos, and that customers may expect to see more usability on the shelves less expanded size and online. Even if the demand is reduced, it will guarantee to offer larger dimensions, but some election framework names now want to pair their plus -sized clothes to exterior vendors instead of making their own labels.

“Many retailers do not want to take the risks themselves, so they want us to make 5xls and 6xls – the special label went for larger dimensions.” He said.

The brand remained as a 5xls and 6xls core seller for the brand, but the demand for 3xls and 4xls increased while people traded in size.

“Your body height and composition are still the same. If you are a longer customer, you will still be longer. You see people from 350 to 320 [pounds]”he said,” they still need larger dimensions.

It is inadequate by plus size segment clothing market

Mallorie Dunn, owner of Smartglamour, a fashion design professor at the Fashion Institute of Technology and a clothing line that offers the smallest and largest dimensions, is concerned about the hurry to the results of the clothing retail market. Dunn says he is concerned that the plus-sized segment is inadequate service before GLP-1 drugs become something.

Dunn, “retailers and manufacturers should not make less plus-sized clothes due to GLP-1 drugs. Plus-dimensional customers, as they stop, they provide a large extent inadequate service-not less, they need more options.” He said. He said that many research studies have been predicted that the majority of American consumers-in the range of 68 to 72%-the majority of American consumers estimated that plus-sized clothing represents only 12% to 18% of income.

“Even if GLP-1 drugs significantly reduce the amount of plus-sized consumers, we will not be close to plus-sized clothes that still produce excessively,” he said.

Kara Richardson Whitely, the founder of the magnificent agency, which helps brands to connect with surplus -sized customers, says that plus -sized clothes are doing this in their own dangers and there are brands that “leave money on the table” brands.

“The existence of these drugs does not mean that fat people do not do suddenly,” Richardson Whitley said. He said.

Richardson Whitley, who has his own battles with his own clothing and plus dimensions, is also the author of Kilimanjaro Yukarı Kimanjaro on the “Gorge: 300 pound, which will be a film produced by the” this Is Us “actress Chrissy Metz.

“While the dimensioning may change, there is still a plus market,” he said.

According to Marty Bauer, the E -commercial director of Omnisend, the online trade platform, the weight loss drugs continue to be a luxury for many Americans, so it is not possible to adopt the mass adoption to reshape the clothing industry until there is a major decrease in drug prices.

While Trump management reduces manufacturers to prices, drug producers may become more accessible to more people, while dealing with efforts to increase market shares after the first explosion period for sales. Novo Nordisk Price discounts, which offer a shorter monthly list price to less than half of the monthly list price through multiple platforms to patients who have recently paid cash in ÖZEMPIC, Hand Lilly The weight loss drug increases distribution options for Zepbound and has a pill alternative that can lead to further updating of groundbreaking drugs.

“For manufacturers, the appearance really depends on how stable demand remains. If sales begin to fall, production can slow down and smaller runs can increase the prices because it is more expensive.” He said.

Meanwhile, when Jennifer returns to Johnson’s re-sales store, he admired his place at the front end of the GLP-1 wave. “We are in the infancy stage of how this will affect people as they get older and continue to use the medicine. Once they reveal itself, we will know the answer.” He said.

Johnson, based on his own research in Ad-Marka Shopping Center clothing retailers, some changes on the shelf are already clear: “All larger dimensions are all in clarity,” Johnson said.